Heidi L. Wagner, J.D.

Heidi L. Wagner, J.D., is senior vice president of government affairs & policy at Global Blood Therapeutics (GBT), a South San Francisco-based biopharmaceutical company focused on developing therapies for sickle cell disease and other unmet needs.  Prior to joining GBT in 2018, Wagner held senior positions at Alexion, Inc., where she built and led the global government affairs function, as well as Genentech, Inc., and has also consulted for a variety of health plans, biopharmaceutical and other health care-related companies.

Wagner has more than 20 years of experience in health care legislative and regulatory policy issues. Her policy expertise broadly encompasses issues relating to biotechnology/pharmaceuticals and public payer policy. She has led numerous federal legislative/regulatory strategic efforts relating to, among other issues, Medicare payment policy, follow-on biologics/biosimilars and HIPAA/health privacy; and advises regularly on the commercial implications of such federal policy and political initiatives. 

Wagner received a bachelor's degree in journalism and mass communication from the University of Colorado in Boulder, and a law degree from the George Mason University School of Law in Virginia.